Lantheus Holdings (LNTH) Change in Inventory (2014 - 2026)
Lantheus Holdings' (LNTH) quarterly Change in Inventory came in at -$2.1 million in Q1 2026, down 660.07% year-on-year from $377273.0 in Q1 2025, and down 169.48% on a QoQ basis from $3.0 million in Q4 2025.
Lantheus Holdings (LNTH) Change in Inventory (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has 13 years of Change in Inventory data on file, last reported at -$2.1 million in Q1 2026.
- On a quarterly basis, Change in Inventory fell 660.07% year-over-year to -$2.1 million in Q1 2026; TTM through Mar 2026 was $7.5 million, a 223.42% increase from a year earlier, with the FY2025 full-year figure at $9.4 million, up 250.79% from the prior year.
- Change in Inventory for Q1 2026 stood at -$2.1 million, down from $3.0 million in the prior quarter.
- Over the last five years, Change in Inventory for LNTH reached as high as $12.1 million in Q2 2023 and fell as low as -$4.4 million in Q4 2024.
- Historically, Change in Inventory has averaged $3.2 million across 5 years, with a median of $2.7 million in 2022.
- Across the five-year window, Change in Inventory surged 3100.79% in 2023 and slumped 660.07% in 2026, its largest moves.
- Year by year, Change in Inventory stood at $2.8 million in 2022, then jumped by 259.78% to $10.2 million in 2023, then tumbled by 143.33% to -$4.4 million in 2024, then jumped by 168.63% to $3.0 million in 2025, then slumped by 169.48% to -$2.1 million in 2026.
- Per Business Quant data, the three most recent Change in Inventory figures were -$2.1 million in Q1 2026, $3.0 million in Q4 2025, and $915000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -93.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 114.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 119.24 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 40.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 123.00 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -4.30 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Lantheus Holdings | 6.72 Bn | 6.22 Bn | 230.92 Mn | -2.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.11 Mn |
| Mar 31, 2026 | -2.11 Mn |
| Dec 31, 2025 | 3.04 Mn |
| Dec 31, 2025 | 3.04 Mn |
| Sep 30, 2025 | 915,000.00 |
| Sep 30, 2025 | 915,000.00 |
| Jun 30, 2025 | 5.69 Mn |
| Jun 30, 2025 | 5.69 Mn |
| Mar 31, 2025 | -278,000.00 |
| Mar 31, 2025 | -278,000.00 |
| Dec 31, 2024 | -4.43 Mn |
| Dec 31, 2024 | -4.43 Mn |
| Sep 30, 2024 | -874,000.00 |
| Sep 30, 2024 | -874,000.00 |
| Jun 30, 2024 | -519,000.00 |
| Jun 30, 2024 | -519,000.00 |
| Mar 31, 2024 | 8.49 Mn |
| Mar 31, 2024 | 8.49 Mn |
| Dec 31, 2023 | 10.23 Mn |
| Dec 31, 2023 | 10.23 Mn |